Physostigmine/Scopolamine

毒扁豆碱/莨菪碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePhysostigmine/Scopolamine
Drug Alias Name毒扁豆碱东莨菪碱Scopolamine/Physostigmine东莨菪碱毒扁豆碱physostigmine + scopolamine东莨菪碱/毒扁豆碱 +[11] 
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase inhibitorsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorAcetylcholinesterase
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes ScopolamineEserine Salicylate
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurobiological Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurobiological Technologies Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A